EDGAR Filing Documents for 0001193125-03-033269

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-03-033269

Filing Date

2003-08-12

Accepted

2003-08-11 19:16:18

Documents

Period of Report

2003-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q FOR PERIOD ENDING 06/30/2003	d10q.htm	10-Q	382934
3	INDENTURE DATED JUNE 23, 2003	dex41.htm	EX-4.1	418194
4	3.50% CONVERTIBLE SUBORDINATED NOTE DUE 2003	dex42.htm	EX-4.2	66502
5	REGISTRATION RIGHTS AGREEMENT DATED JUNE 23, 2003	dex43.htm	EX-4.3	114315
6	AMENDMENT NO.2 TO 1998 DIRECTOR OPTION PLAN	dex101.htm	EX-10.1	5493
7	BAYVIEW BUSINESS PARK STANDARD LEASE	dex102.htm	EX-10.2	292585
8	NOTE PURCHASE AGREEMENT DATED JUNE 18, 2003	dex103.htm	EX-10.3	197872
9	CERTIFICATION OF CEO AND CFO	dex311.htm	EX-31.1	3098
10	CERTIFICATION OF CEO PURSUANT TO 18 U.S.C.	dex321.htm	EX-32.1	10243
11	CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350	dex322.htm	EX-32.2	10045
	Complete submission text file	0001193125-03-033269.txt		1504073

Mailing Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949

Business Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949 4158846700

BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)